Atlas Trials

Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer

RecordFirmDate
A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT02838420)Hoffmann-La Roche2016-08-03

Track Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.